Ionis Pharmaceuticals
IONS • NASDAQ
Ionis Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Brett Monia, with a market cap of $11.9B.
CEOBrett Monia
Next Earnings
Upcoming earnings announcement for Ionis Pharmaceuticals
Date
Wednesday, April 29, 2026 (in 4 weeks)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.79
Revenue Estimate
$197.4M
Earnings History
Past 12 earnings reports for Ionis Pharmaceuticals
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 25, 2026 | Q4 2025 | -$1.15Est: -$1.26 | +8.7% | $203.0MEst: $155.9M | +30.2% |  10-K |
| Oct 29, 2025 | Q3 2025 | -$0.61Est: -$1.12 | +45.3% | $157.0MEst: $130.3M | +20.5% | 10-Q |
| Jul 30, 2025 | Q2 2025 | $0.85Est: $0.16 | +431.3% | $452.0MEst: $287.7M | +57.1% | 10-Q |
| Apr 30, 2025 | Q1 2025 | -$0.93Est: -$1.03 | +9.7% | $132.0MEst: $122.5M | +7.7% | 10-Q |
| Feb 19, 2025 | Q4 2024 | -$0.43Est: -$0.84 | +48.8% | $227.0MEst: $141.0M | +61.1% | 10-K |
| Nov 6, 2024 | Q3 2024 | -$0.72Est: -$1.16 | +37.9% | $134.0MEst: $129.9M | +3.2% | 10-Q |
| Aug 1, 2024 | Q2 2024 | -$0.24Est: -$0.95 | +74.7% | $225.0MEst: $146.0M | +54.1% | 10-Q |
| May 7, 2024 | Q1 2024 | -$0.77Est: -$1.03 | +25.2% | $119.0MEst: $138.3M | -13.9% | 10-Q |
| Feb 21, 2024 | Q4 2023 | -$0.06Est: -$0.83 | +92.8% | $325.0MEst: $174.8M | +86.0% | 10-K |
| Nov 2, 2023 | Q3 2023 | -$0.85Est: -$1.07 | +20.6% | $144.0MEst: $132.9M | +8.4% | — |
| Aug 9, 2023 | Q2 2023 | -$0.41Est: -$0.90 | +54.4% | $188.0MEst: $138.8M | +35.4% | 10-Q |
| May 3, 2023 | Q1 2023 | -$0.68Est: -$0.91 | +25.3% | $131.0MEst: $128.1M | +2.2% | — |